Stage FocusSeries A, Series B+
GeographyChina
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTechAI Infrastructure
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Shenzhen Oriental Fortune Capital is a major Chinese VC managing ¥20B+ (RMB) since 2006, with a portfolio of 500+ companies and 100+ IPO exits. The fund focuses on healthcare, biopharma, medical devices, and life sciences while also being active in hard tech sectors including semiconductors, advanced manufacturing, and new materials.
Government-backed with deep connections to the Shenzhen ecosyst...
Notable Investments
F
Fosun PharmaW
Walvax BiotechnologySimilar Funds
Ally Bridge Group
New York, United States
DeepTech NativeBiotechMedTechSeries ASeries B+
ARTIS Ventures
San Francisco, United States
DeepTech NativeBiotechAI InfrastructureMedTechSeedSeries A
Foresite Capital
San Francisco, United States
DeepTech NativeBiotechMedTechAI InfrastructureSeedSeries A
Lilly Asia Ventures
Shanghai, China
DeepTech NativeBiotechMedTechSynthetic BiologySeries ASeries B+
LYFE Capital
Singapore, Singapore
DeepTech NativeBiotechMedTechSeries ASeries B+
Osage University Partners
Bala Cynwyd, United States
DeepTech NativeBiotechMedTechClimate TechSeedSeries A